{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:26:05Z","timestamp":1792016765771,"version":"4.4.0"},"reference-count":127,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Neurodegenerative diseases, such as Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), Huntington\u2019s disease (HD), and amyotrophic lateral sclerosis (ALS), represent a growing societal challenge due to their irreversible progression and significant impact on patients, caregivers, and healthcare systems. Despite advances in clinical and imaging-based diagnostics, these diseases are often detected at advanced stages, limiting the effectiveness of therapeutic interventions. Recent breakthroughs in genomic and transcriptomic technologies, including whole-genome sequencing, single-cell RNA sequencing (scRNA-seq), and CRISPR-based screens, have revolutionized the field, offering new avenues for early diagnosis and personalized prognosis. Genomic approaches have elucidated disease-specific genetic risk factors and molecular pathways, while transcriptomic studies have identified stage-specific biomarkers that correlate with disease progression and severity. Furthermore, genome-wide association studies (GWAS), polygenic risk scores (PRS), and spatial transcriptomics are enabling the stratification of patients based on their risk profiles and prognostic trajectories. Advances in functional genomics have uncovered actionable targets, such as ATXN2 in ALS and TREM2 in AD, paving the way for tailored therapeutic strategies. Despite these achievements, challenges remain in translating genomic discoveries into clinical practice due to disease heterogeneity and the complexity of neurodegenerative pathophysiology. Future integration of genetic technologies holds promise for transforming diagnostic and prognostic paradigms, offering hope for improved patient outcomes and precision medicine approaches.<\/jats:p>","DOI":"10.3390\/genes16020135","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T07:33:11Z","timestamp":1737703991000},"page":"135","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3264-7119","authenticated-orcid":false,"given":"Zheng","family":"Liu","sequence":"first","affiliation":[{"name":"Pathology Department, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ciurea, A.V., Mohan, A.G., Covache-Busuioc, R.-A., Costin, H.-P., Glavan, L.-A., Corlatescu, A.-D., and Saceleanu, V.M. (2023). Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer\u2019s, Parkinson\u2019s, and Huntington\u2019s Diseases and Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202305.1229.v1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1038\/s41467-024-46554-8","article-title":"Neuropathogenesis-on-Chips for Neurodegenerative Diseases","volume":"15","author":"Amartumur","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Erkkinen, M.G., Kim, M.-O., and Geschwind, M.D. (2018). Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harb. Perspect. Biol., 10.","DOI":"10.1101\/cshperspect.a033118"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102357","DOI":"10.1016\/j.arr.2024.102357","article-title":"Neurodegenerative Disorders: Mechanisms of Degeneration and Therapeutic Approaches with Their Clinical Relevance","volume":"99","author":"Gadhave","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The Blood-Brain Barrier in Aging and Neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Alkhalifa, A.E., Al-Ghraiybah, N.F., Odum, J., Shunnarah, J.G., Austin, N., and Kaddoumi, A. (2023). Blood-Brain Barrier Breakdown in Alzheimer\u2019s Disease: Mechanisms and Targeted Strategies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216288"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","article-title":"The Interplay of Aging, Genetics and Environmental Factors in the Pathogenesis of Parkinson\u2019s Disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer\u2019s Disease Facts and Figures","volume":"20","author":"Better","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The Neuropathological Diagnosis of Alzheimer\u2019s Disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e209925","DOI":"10.1212\/WNL.0000000000209925","article-title":"End-of-Life Health Care Service Use and Cost Among Medicare Decedents With Neurodegenerative Diseases","volume":"103","author":"Aamodt","year":"2024","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/1567205013666151116141603","article-title":"Diagnosis of Neurodegenerative Diseases: The Clinical Approach","volume":"13","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Luebke, M., Parulekar, M., and Thomas, F.P. (2023). Fluid Biomarkers for the Diagnosis of Neurodegenerative Diseases. Biomark. Neuropsychiatry, 8.","DOI":"10.1016\/j.bionps.2023.100062"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Aus\u00f3, E., G\u00f3mez-Vicente, V., and Esquiva, G. (2020). Biomarkers for Alzheimer\u2019s Disease Early Diagnosis. J. Pers. Med., 10.","DOI":"10.3390\/jpm10030114"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","article-title":"Depletion of Dopamine in Parkinson\u2019s Disease and Relevant Therapeutic Options: A Review of the Literature","volume":"10","author":"Ramesh","year":"2023","journal-title":"AIMS Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"a009258","DOI":"10.1101\/cshperspect.a009258","article-title":"Parkinson\u2019s Disease and Parkinsonism: Neuropathology","volume":"2","author":"Dickson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-024-00407-y","article-title":"Overlaps and Divergences between Tauopathies and Synucleinopathies: A Duet of Neurodegeneration","volume":"13","author":"Li","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1038\/s41467-018-05892-0","article-title":"Uncovering the Heterogeneity and Temporal Complexity of Neurodegenerative Diseases with Subtype and Stage Inference","volume":"9","author":"Young","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/gim.2016.107","article-title":"Genetic Testing and Genetic Counseling for Amyotrophic Lateral Sclerosis: An Update for Clinicians","volume":"19","author":"Roggenbuck","year":"2017","journal-title":"Genet. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Roberts, J.S., Patterson, A.K., and Uhlmann, W.R. (2020). Genetic Testing for Neurodegenerative Diseases: Ethical and Health Communication Challenges. Neurobiol. Dis., 141.","DOI":"10.1016\/j.nbd.2020.104871"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kon\u00ed\u010dkov\u00e1, D., Men\u0161\u00edkov\u00e1, K., Tu\u010dkov\u00e1, L., H\u00e9nykov\u00e1, E., Strnad, M., Friedeck\u00fd, D., Stejskal, D., Mat\u011bj, R., and Ka\u0148ovsk\u00fd, P. (2022). Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071760"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102180","DOI":"10.1016\/j.arr.2023.102180","article-title":"Pangenomics: A New Era in the Field of Neurodegenerative Diseases","volume":"94","author":"Abondio","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lanoisel\u00e9e, H.-M., Nicolas, G., Wallon, D., Rovelet-Lecrux, A., Lacour, M., Rousseau, S., Richard, A.-C., Pasquier, F., Rollin-Sillaire, A., and Martinaud, O. (2017). APP, PSEN1, and PSEN2 Mutations in Early-Onset Alzheimer Disease: A Genetic Screening Study of Familial and Sporadic Cases. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002270"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Xiao, X., Liu, H., Liu, X., Zhang, W., Zhang, S., and Jiao, B. (2021). APP, PSEN1, and PSEN2 Variants in Alzheimer\u2019s Disease: Systematic Re-Evaluation According to ACMG Guidelines. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.695808"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41531-020-0110-8","article-title":"Genetic Predispositions of Parkinson\u2019s Disease Revealed in Patient-Derived Brain Cells","volume":"6","author":"Tran","year":"2020","journal-title":"Npj Park. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.molmed.2017.04.006","article-title":"Single-Cell RNA Sequencing: Unraveling the Brain One Cell at a Time","volume":"23","author":"Ofengeim","year":"2017","journal-title":"Trends Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e2210712120","DOI":"10.1073\/pnas.2210712120","article-title":"Integrated Regulation of Dopaminergic and Epigenetic Effectors of Neuroprotection in Parkinson\u2019s Disease Models","volume":"120","author":"Nourse","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2217\/fnl.09.78","article-title":"Early Detection of Huntington Disease","volume":"5","author":"Paulsen","year":"2010","journal-title":"Future Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1002\/hbm.24517","article-title":"Effective Connectivity in the Default Mode Network Is Distinctively Disrupted in Alzheimer\u2019s Disease-A Simultaneous Resting-State FDG-PET\/fMRI Study","volume":"42","author":"Scherr","year":"2021","journal-title":"Hum. Brain Mapp."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s Disease: Pathophysiology and Therapeutic Strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00234-021-02761-4","article-title":"A Novel CT-Based Automated Analysis Method Provides Comparable Results with MRI in Measuring Brain Atrophy and White Matter Lesions","volume":"63","author":"Kaipainen","year":"2021","journal-title":"Neuroradiology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/awab404","article-title":"Preventing Amyotrophic Lateral Sclerosis: Insights from Pre-Symptomatic Neurodegenerative Diseases","volume":"145","author":"Benatar","year":"2022","journal-title":"Brain"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s Disease: Etiopathogenesis and Treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_33","first-page":"1401","article-title":"Alzheimer\u2019s Disease and Language Impairments: Social Intervention and Medical Treatment","volume":"10","author":"Klimova","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Silva, M.V.F., Loures, C.D.M.G., Alves, L.C.V., De Souza, L.C., Borges, K.B.G., and Carvalho, M.D.G. (2019). Alzheimer\u2019s Disease: Risk Factors and Potentially Protective Measures. J. Biomed. Sci., 26.","DOI":"10.1186\/s12929-019-0524-y"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic Lateral Sclerosis: A Clinical Review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/mdc3.12312","article-title":"Huntington\u2019s Disease, Huntington\u2019s Disease Look-Alikes, and Benign Hereditary Chorea: What\u2019s New?","volume":"3","author":"Schneider","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Wakasugi, N., and Hanakawa, T. (2021). It Is Time to Study Overlapping Molecular and Circuit Pathophysiologies in Alzheimer\u2019s and Lewy Body Disease Spectra. Front. Syst. Neurosci., 15.","DOI":"10.3389\/fnsys.2021.777706"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1017\/S135561772000048X","article-title":"Montreal Cognitive Assessment (MoCA) Performance and Domain-Specific Index Scores in Amnestic Versus Aphasic Dementia","volume":"26","author":"Wood","year":"2020","journal-title":"J. Int. Neuropsychol. Soc. JINS"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"56285","DOI":"10.12775\/QS.2024.34.56285","article-title":"Cognitive Function Tests: Application of MMSE and MoCA in Various Clinical Settings- a Brief Overview","volume":"34","author":"Oleksy","year":"2024","journal-title":"Qual. Sport"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13195-024-01399-7","article-title":"Relationships of Change in Clinical Dementia Rating (CDR) on Patient Outcomes and Probability of Progression: Observational Analysis","volume":"16","author":"Tariot","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type","volume":"9","author":"Morris","year":"1997","journal-title":"Int. Psychogeriatr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cnp.2023.12.003","article-title":"Diagnosis and Differential Diagnosis of MND\/ALS: IFCN Handbook Chapter","volume":"9","author":"Swash","year":"2024","journal-title":"Clin. Neurophysiol. Pract."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"426","DOI":"10.14283\/jpad.2023.43","article-title":"Diagnostic Biomarkers of Amyloid and Tau Pathology in Alzheimer\u2019s Disease: An Overview of Tests for Clinical Practice in the United States and Europe","volume":"10","author":"Iaccarino","year":"2023","journal-title":"J. Prev. Alzheimers Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/alz.12316","article-title":"The Alzheimer\u2019s Association International Guidelines for Handling of Cerebrospinal Fluid for Routine Clinical Measurements of Amyloid \u03b2 and Tau","volume":"17","author":"Hansson","year":"2021","journal-title":"Alzheimers Dement."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cca.2019.04.078","article-title":"Parkinson\u2019s and Lewy Body Dementia CSF Biomarkers","volume":"495","author":"Parnetti","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","article-title":"Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders","volume":"57","author":"Alirezaei","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"O\u2019Day, D.H. (2023). Protein Biomarkers Shared by Multiple Neurodegenerative Diseases Are Calmodulin-Binding Proteins Offering Novel and Potentially Universal Therapeutic Targets. J. Clin. Med., 12.","DOI":"10.3390\/jcm12227045"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.parkreldis.2019.02.014","article-title":"Salivary Alpha-Synuclein in the Diagnosis of Parkinson\u2019s Disease and Progressive Supranuclear Palsy","volume":"63","author":"Vivacqua","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40120-019-00168-1","article-title":"Salivary Biomarkers for Alzheimer\u2019s Disease and Related Disorders","volume":"8","author":"Ashton","year":"2019","journal-title":"Neurol. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000154597.24838.6B","article-title":"Urinary 8-Hydroxydeoxyguanosine Levels as a Biomarker for Progression of Parkinson Disease","volume":"64","author":"Sato","year":"2005","journal-title":"Neurology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"fcad287","DOI":"10.1093\/braincomms\/fcad287","article-title":"Urinary Biomarkers for Amyotrophic Lateral Sclerosis: Candidates, Opportunities and Considerations","volume":"5","author":"Rogers","year":"2023","journal-title":"Brain Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/brain\/awm016","article-title":"Different Regional Patterns of Cortical Thinning in Alzheimer\u2019s Disease and Frontotemporal Dementia","volume":"130","author":"Du","year":"2007","journal-title":"Brain J. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/hbm.23192","article-title":"Diffusion Tensor Imaging of the Substantia Nigra in Parkinson\u2019s Disease Revisited","volume":"37","author":"Langley","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","article-title":"Onset and Rate of Striatal Atrophy in Preclinical Huntington Disease","volume":"63","author":"Aylward","year":"2004","journal-title":"Neurology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.31083\/j.jin2103087","article-title":"Neurometabolic Alterations in Motor Neuron Disease: Insights from Magnetic Resonance Spectroscopy","volume":"21","author":"Christidi","year":"2022","journal-title":"J. Integr. Neurosci."},{"key":"ref_56","first-page":"661","article-title":"Uses of Human MR and PET Imaging in Research of Neurodegenerative Brain Diseases","volume":"18","author":"Schwarz","year":"2021","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of Florbetapir-PET for Imaging \u03b2-Amyloid Pathology","volume":"305","author":"Clark","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13195-020-00587-5","article-title":"Comparison of Amyloid PET Measured in Centiloid Units with Neuropathological Findings in Alzheimer\u2019s Disease","volume":"12","author":"Amadoru","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"fcad305","DOI":"10.1093\/braincomms\/fcad305","article-title":"A Review of the Flortaucipir Literature for Positron Emission Tomography Imaging of Tau Neurofibrillary Tangles","volume":"6","author":"Burnham","year":"2023","journal-title":"Brain Commun."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Cheng, F., Duan, Y., Jiang, H., Zeng, Y., Chen, X., Qin, L., Zhao, L., Yi, F., Tang, Y., and Liu, C. (2022). Identifying and Distinguishing of Essential Tremor and Parkinson\u2019s Disease with Grouped Stability Analysis Based on Searchlight-Based MVPA. Biomed. Eng. Online, 21.","DOI":"10.1186\/s12938-022-01050-2"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Michels, S., Buchholz, H.-G., Rosar, F., Heinrich, I., Hoffmann, M.A., Schweiger, S., T\u00fcscher, O., and Schreckenberger, M. (2019). 18F-FDG PET\/CT: An Unexpected Case of Huntington\u2019s Disease. BMC Neurol., 19.","DOI":"10.1186\/s12883-019-1311-9"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"kkad009","DOI":"10.1093\/psyrad\/kkad009","article-title":"Neuroimaging Modalities in the Detection of Alzheimer\u2019s Disease-Associated Biomarkers","volume":"3","author":"Dang","year":"2023","journal-title":"Psychoradiology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","article-title":"Common and Rare Variant Association Analyses in Amyotrophic Lateral Sclerosis Identify 15 Risk Loci with Distinct Genetic Architectures and Neuron-Specific Biology","volume":"53","author":"Bakker","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/alz.12319","article-title":"Whole-Genome Sequencing Reveals New Alzheimer\u2019s Disease-Associated Rare Variants in Loci Related to Synaptic Function and Neuronal Development","volume":"17","author":"Prokopenko","year":"2021","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","article-title":"Genome Sequencing Analysis Identifies New Loci Associated with Lewy Body Dementia and Provides Insights into Its Genetic Architecture","volume":"53","author":"Chia","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/acn3.51744","article-title":"C9orf72 Expansions Are the Most Common Cause of Genetic Frontotemporal Dementia in a Southeast Asian Cohort","volume":"10","author":"Tan","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Bagyinszky, E., Giau, V.V., and An, S.A. (2020). Transcriptomics in Alzheimer\u2019s Disease: Aspects and Challenges. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103517"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.1007\/s12035-024-04124-5","article-title":"Transcriptomics of Human Brain Tissue in Parkinson\u2019s Disease: A Comparison of Bulk and Single-Cell RNA Sequencing","volume":"61","author":"Fiorini","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"dmm049418","DOI":"10.1242\/dmm.049418","article-title":"Transcriptional Targets of Amyotrophic Lateral Sclerosis\/Frontotemporal Dementia Protein TDP-43\u2014Meta-Analysis and Interactive Graphical Database","volume":"15","author":"Cao","year":"2022","journal-title":"Dis. Model. Mech."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"108263","DOI":"10.1016\/j.celrep.2020.108263","article-title":"Single-Cell Transcriptomics of Parkinson\u2019s Disease Human In Vitro Models Reveals Dopamine Neuron-Specific Stress Responses","volume":"33","author":"Fernandes","year":"2020","journal-title":"Cell Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00401-020-02200-3","article-title":"APOE and TREM2 Regulate Amyloid-Responsive Microglia in Alzheimer\u2019s Disease","volume":"140","author":"Nguyen","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1523\/JNEUROSCI.2074-20.2021","article-title":"Single-Nucleus RNA-Seq Reveals Dysregulation of Striatal Cell Identity Due to Huntington\u2019s Disease Mutations","volume":"41","author":"Malaiya","year":"2021","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1038\/s41467-023-42751-z","article-title":"Spatial Transcriptomics Reveals Unique Gene Expression Changes in Different Brain Regions after Sleep Deprivation","volume":"14","author":"Vanrobaeys","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/s12276-023-01093-y","article-title":"Spatial Transcriptomics in Neuroscience","volume":"55","author":"Jung","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2020.06.038","article-title":"Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer\u2019s Disease","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s40478-022-01494-6","article-title":"Spatially Resolved Transcriptomics Reveals Genes Associated with the Vulnerability of Middle Temporal Gyrus in Alzheimer\u2019s Disease","volume":"10","author":"Chen","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"113691","DOI":"10.1016\/j.celrep.2024.113691","article-title":"Spatial Transcriptomic Patterns Underlying Amyloid-\u03b2 and Tau Pathology Are Associated with Cognitive Dysfunction in Alzheimer\u2019s Disease","volume":"43","author":"Yu","year":"2024","journal-title":"Cell Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41380-024-02651-0","article-title":"Single-Cell Spatial Transcriptomics Reveals Distinct Patterns of Dysregulation in Non-Neuronal and Neuronal Cells Induced by the Trem2R47H Alzheimer\u2019s Risk Gene Mutation","volume":"30","author":"Johnston","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","article-title":"Single-Cell Genomic Profiling of Human Dopamine Neurons Identifies a Population That Selectively Degenerates in Parkinson\u2019s Disease","volume":"25","author":"Kamath","year":"2022","journal-title":"Nat. Neurosci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1093\/brain\/awae123","article-title":"Spatial Enrichment and Genomic Analyses Reveal the Link of NOMO1 with Amyotrophic Lateral Sclerosis","volume":"147","author":"Guo","year":"2024","journal-title":"Brain"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41582-023-00809-y","article-title":"Single-Cell and Spatial Transcriptomics: Deciphering Brain Complexity in Health and Disease","volume":"19","author":"Piwecka","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"eaal5209","DOI":"10.1126\/scitranslmed.aal5209","article-title":"Improving Genetic Diagnosis in Mendelian Disease with Transcriptome Sequencing","volume":"9","author":"Cummings","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1038\/s41467-024-49133-z","article-title":"A Single-Cell and Spatial RNA-Seq Database for Alzheimer\u2019s Disease (ssREAD)","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.4103\/1673-5374.371364","article-title":"Combination of Novel RNA Sequencing and Sophisticated Network Modeling to Reveal a Common Denominator in Amyotrophic Lateral Sclerosis?","volume":"18","author":"Dash","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"365","DOI":"10.62641\/aep.v52i3.1595","article-title":"An Epigenetic Manifestation of Alzheimer\u2019s Disease: DNA Methylation","volume":"52","author":"Feng","year":"2024","journal-title":"Actas Esp. Psiquiatr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3233\/ADR-220109","article-title":"Utility of DNA Methylation as a Biomarker in Aging and Alzheimer\u2019s Disease","volume":"7","author":"Milicic","year":"2023","journal-title":"J. Alzheimers Dis. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41392-024-02030-9","article-title":"Chromatin Accessibility: Biological Functions, Molecular Mechanisms and Therapeutic Application","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"fcae265","DOI":"10.1093\/braincomms\/fcae265","article-title":"Integrative Approach of Omics and Imaging Data to Discover New Insights for Understanding Brain Diseases","volume":"6","author":"Yoon","year":"2024","journal-title":"Brain Commun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"107247","DOI":"10.1016\/j.phrs.2024.107247","article-title":"Advancing Personalized Medicine in Neurodegenerative Diseases: The Role of Epigenetics and Pharmacoepigenomics in Pharmacotherapy","volume":"205","author":"Guerrero","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2008.07.003","article-title":"Proteomics in Animal Models of Alzheimer\u2019s and Parkinson\u2019s Diseases","volume":"8","author":"Sowell","year":"2009","journal-title":"Ageing Res. Rev."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41386-020-00840-3","article-title":"Systems-Based Proteomics to Resolve the Biology of Alzheimer\u2019s Disease beyond Amyloid and Tau","volume":"46","author":"Rayaprolu","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1586\/14789450.2016.1149470","article-title":"Clinical Implications from Proteomic Studies in Neurodegenerative Diseases: Lessons from Mitochondrial Proteins","volume":"13","author":"Butterfield","year":"2016","journal-title":"Expert Rev. Proteom."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41531-024-00732-z","article-title":"Identification of Metabolites Reproducibly Associated with Parkinson\u2019s Disease via Meta-Analysis and Computational Modelling","volume":"10","author":"Luo","year":"2024","journal-title":"Npj Park. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid Metabolism and Alzheimer\u2019s Disease: Clinical Evidence, Mechanistic Link and Therapeutic Promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12944-023-01918-9","article-title":"Identification of Key Lipid Metabolism-Related Genes in Alzheimer\u2019s Disease","volume":"22","author":"Zeng","year":"2023","journal-title":"Lipids Health Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mds.29739","article-title":"Parkin mRNA Expression Levels in Peripheral Blood Mononuclear Cells in Parkin-Related Parkinson\u2019s Disease","volume":"39","author":"Papagiannakis","year":"2024","journal-title":"Mov. Disord."},{"key":"ref_98","first-page":"137","article-title":"Integration of Targeted Metabolomics and Transcriptomics Identifies Deregulation of Phosphatidylcholine Metabolism in Huntington\u2019s Disease Peripheral Blood Samples","volume":"12","author":"Mastrokolias","year":"2016","journal-title":"Metabolomics Off. J. Metabolomic Soc."},{"key":"ref_99","first-page":"205","article-title":"Transcriptomics and Metabolomics in Amyotrophic Lateral Sclerosis","volume":"Volume 1195","author":"Vlamos","year":"2020","journal-title":"GeNeDis 2018"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","article-title":"TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer\u2019s Disease","volume":"103","author":"Griciuc","year":"2019","journal-title":"Neuron"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Broadway, B.J., Boneski, P.K., Bredenberg, J.M., Kolicheski, A., Hou, X., Soto-Beasley, A.I., Ross, O.A., Springer, W., and Fiesel, F.C. (2022). Systematic Functional Analysis of PINK1 and PRKN Coding Variants. Cells, 11.","DOI":"10.3390\/cells11152426"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Behl, T., Kaur, I., Sehgal, A., Singh, S., Albarrati, A., Albratty, M., Najmi, A., Meraya, A.M., and Bungau, S. (2022). The Road to Precision Medicine: Eliminating the \u201cOne Size Fits All\u201d Approach in Alzheimer\u2019s Disease. Biomed. Pharmacother., 153.","DOI":"10.1016\/j.biopha.2022.113337"},{"key":"ref_103","first-page":"948","article-title":"DNA Damage Repair in Huntington\u2019s Disease and Other Neurodegenerative Diseases","volume":"16","author":"Maiuri","year":"2019","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ajhg.2022.03.004","article-title":"Genetic Modifiers of Huntington Disease Differentially Influence Motor and Cognitive Domains","volume":"109","author":"Lee","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Smith, L., and Schapira, A.H.V. (2022). GBA Variants and Parkinson Disease: Mechanisms and Treatments. Cells, 11.","DOI":"10.3390\/cells11081261"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Vinagre-Arag\u00f3n, A., Campo-Caballero, D., Mondrag\u00f3n-Rezola, E., Pardina-Vilella, L., Hernandez Eguiazu, H., Gorostidi, A., Croitoru, I., Bergareche, A., and Ruiz-Martinez, J. (2021). A More Homogeneous Phenotype in Parkinson\u2019s Disease Related to R1441G Mutation in the LRRK2 Gene. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.635396"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Fan, X., and Li, H. (2024). Integration of Single-Cell and Spatial Transcriptomic Data Reveals Spatial Architecture and Potential Biomarkers in Alzheimer\u2019s Disease. Mol. Neurobiol.","DOI":"10.1007\/s12035-024-04617-3"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in Neurodegenerative Diseases: Mechanism and Potential Therapeutic Targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s40478-024-01803-1","article-title":"Single-Nucleus Multi-Omics of Parkinson\u2019s Disease Reveals a Glutamatergic Neuronal Subtype Susceptible to Gene Dysregulation via Alteration of Transcriptional Networks","volume":"12","author":"Shwab","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"107833","DOI":"10.1016\/j.isci.2023.107833","article-title":"Bibliometric Analysis of Research on Neurodegenerative Diseases and Single-Cell RNA Sequencing: Opportunities and Challenges","volume":"26","author":"Wang","year":"2023","journal-title":"iScience"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-220025","article-title":"Polygenic Risk Scores in Alzheimer\u2019s Disease Genetics: Methodology, Applications, Inclusion, and Diversity","volume":"89","author":"Clark","year":"2022","journal-title":"J. Alzheimers Dis. JAD"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"14774","DOI":"10.1038\/ncomms14774","article-title":"Genetic Correlation between Amyotrophic Lateral Sclerosis and Schizophrenia","volume":"8","author":"McLaughlin","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e12188","DOI":"10.15252\/emmm.202012188","article-title":"Targeted Attenuation of Elevated Histone Marks at SNCA Alleviates \u03b1-Synuclein in Parkinson\u2019s Disease","volume":"13","author":"Guhathakurta","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"ref_114","first-page":"1145","article-title":"Antisense Oligonucleotides for the Study and Treatment of ALS","volume":"19","author":"Boros","year":"2022","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting Huntingtin Expression in Patients with Huntington\u2019s Disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_116","first-page":"S183","article-title":"Gene Therapy for Parkinson\u2019s Disease Associated with GBA1 Mutations","volume":"11","author":"Abeliovich","year":"2021","journal-title":"J. Park. Dis."},{"key":"ref_117","first-page":"567","article-title":"CRISPR\/Cas9 Genome Editing for Neurodegenerative Diseases","volume":"22","year":"2023","journal-title":"EXCLI J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/hmg\/ddx286","article-title":"A Modifier of Huntington\u2019s Disease Onset at the MLH1 Locus","volume":"26","author":"Lee","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/hmg\/ddy375","article-title":"FAN1 Modifies Huntington\u2019s Disease Progression by Stabilizing the Expanded HTT CAG Repeat","volume":"28","author":"Goold","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease","volume":"169","author":"Spinrad","year":"2017","journal-title":"Cell"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.aav9776","article-title":"Spatiotemporal Dynamics of Molecular Pathology in Amyotrophic Lateral Sclerosis","volume":"364","author":"Maniatis","year":"2019","journal-title":"Science"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"eabf7906","DOI":"10.1126\/sciadv.abf7906","article-title":"FAN1-MLH1 Interaction Affects Repair of DNA Interstrand Cross-Links and Slipped-CAG\/CTG Repeats","volume":"7","author":"Porro","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"107127","DOI":"10.1016\/j.parkreldis.2024.107127","article-title":"Cognitive Phenotyping of GBA1-Parkinson\u2019s Disease: A Study on Deep Brain Stimulation Outcomes","volume":"128","author":"Campolongo","year":"2024","journal-title":"Park. Relat. Disord."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1523\/JNEUROSCI.2427-21.2022","article-title":"Microglial mTOR Activation Upregulates Trem2 and Enhances \u03b2-Amyloid Plaque Clearance in the 5XFAD Alzheimer\u2019s Disease Model","volume":"42","author":"Shi","year":"2022","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00401-023-02659-w","article-title":"CSF P-Tau205: A Biomarker of Tau Pathology in Alzheimer\u2019s Disease","volume":"147","author":"Benedet","year":"2024","journal-title":"Acta Neuropathol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-022-00281-6","article-title":"LRRK2, GBA and Their Interaction in the Regulation of Autophagy: Implications on Therapeutics in Parkinson\u2019s Disease","volume":"11","author":"Pang","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/iid3.362","article-title":"What Has Single-Cell RNA Sequencing Revealed about Microglial Neuroimmunology?","volume":"8","author":"Kubick","year":"2020","journal-title":"Immun. Inflamm. Dis."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/2\/135\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:35:11Z","timestamp":1759919711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/2\/135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":127,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["genes16020135"],"URL":"https:\/\/doi.org\/10.3390\/genes16020135","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]}}}